Shanghai Pharma eyes $1.5B public offering

Shanghai Pharmaceuticals, Roche's Chinese partner and the second-largest drugmaker in that country, plans to raise $1.2 billion to $1.5 billion in a Hong Kong IPO in the second quarter of 2011, sources close to the deal say. Report